7[2]Linz W, Wiemer G, Schaper J, et al. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis. Mol Cell Biochem, 1995,147:89-97.
8[3]Long C S, Kariya K I, Karns L, et al. Sympathetic activity: Modulator of myocardial hypertrophy. J Cardiovasc Pharmacol, 1991,17(Suppl 2):S 20-24.
9[4]Dhalla A K, Dawan K S. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol, 1994,266: 1280-1289.
10[5]Ganguly P K, Sherwood G R. Noradrenaline turnover and metabolism in myocardium following aortic constriction in rats. Cardiovasc Res, 1991,25:579-585.
